{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:59:01Z","timestamp":1792853941566,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kollegium f\u00fcr Hausarztmedizin"},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["grant agreement No 101057123"],"award-info":[{"award-number":["grant agreement No 101057123"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss State Secretariat for Education, Research and Innovation","award":["contract No 22.00116"],"award-info":[{"award-number":["contract No 22.00116"]}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["Ambizione Grant PZ00P3_201672"],"award-info":[{"award-number":["Ambizione Grant PZ00P3_201672"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Benzodiazepines and other sedative hypnotic drugs (BSHs) are frequently prescribed for sleep problems, but cause substantial adverse effects, particularly in older adults. Improving knowledge on barriers, facilitators and needs of primary care providers (PCPs) to BSH deprescribing could help reduce BSH use and thus negative effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a mixed methods study (February-May 2023) including a survey, semi-structured interviews and focus groups with PCPs in Switzerland. We assessed barriers, facilitators and needs of PCPs to BSH deprescribing. Quantitative data were analyzed descriptively, qualitative data deductively and inductively using the Theoretical Domain Framework (TDF). Quantitative and qualitative data were integrated using meta-interferences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The survey was completed by 126 PCPs (53% female) and 16 PCPs participated to a focus group or individual interview. The main barriers to BSH deprescribing included patient and PCP lack of knowledge on BSH effects and side effects, lack of PCP education on treatment of sleep problems and BSH deprescribing, patient lack of motivation, PCP lack of time, limited access to cognitive behavioral therapy for insomnia and absence of public dialogue on BSHs. Facilitators included informing on side effects to motivate patients to discontinue BSHs and start of deprescribing during a hospitalization. Main PCP needs were practical recommendations for pharmacological and non-pharmacological treatment of sleep problems and deprescribing schemes. Patient brochures were wished by 69% of PCPs. PCPs suggested the brochures to contain explanations about risks and benefits of BSHs, sleep hygiene and sleep physiology, alternative treatments, discontinuation process and tapering schemes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The barriers and facilitators as well as PCP needs and opinions on patient material we identified can be used to develop PCP training and material on BSH deprescribing, which could help reduce the inappropriate use of BSHs for sleep problems.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-05027-9","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T04:01:49Z","timestamp":1714795309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Barriers, facilitators and needs to deprescribe benzodiazepines and other sedatives in older adults: a mixed methods study of primary care provider perspectives"],"prefix":"10.1186","volume":"24","author":[{"given":"Orlando","family":"H\u00fcrlimann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Alers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Hauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Bolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8325-8784","authenticated-orcid":false,"given":"Carole E.","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"issue":"6","key":"5027_CR1","doi-asserted-by":"publisher","first-page":"e14035","DOI":"10.1111\/jsr.14035","volume":"32","author":"D Riemann","year":"2023","unstructured":"Riemann D, Espie CA, Altena E, Arnardottir ES, Baglioni C, Bassetti CLA, et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32(6):e14035.","journal-title":"J Sleep Res"},{"issue":"7","key":"5027_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2023","unstructured":"By the American Geriatrics Society Beers Criteria Update Expert P. American Geriatrics Society 2023 updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201381.","journal-title":"J Am Geriatr Soc."},{"issue":"1","key":"5027_CR3","doi-asserted-by":"publisher","first-page":"e031156","DOI":"10.1136\/bmjopen-2019-031156","volume":"10","author":"X Luta","year":"2020","unstructured":"Luta X, Bagnoud C, Lambiris M, Decollogny A, Eggli Y, Le Pogam MA, et al. Patterns of benzodiazepine prescription among older adults in Switzerland: a cross-sectional analysis of claims data. BMJ Open. 2020;10(1):e031156.","journal-title":"BMJ Open"},{"issue":"1","key":"5027_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.12927\/hcq.2015.24250","volume":"18","author":"J Proulx","year":"2015","unstructured":"Proulx J, Hunt J. Drug Use among Seniors on Public Drug Programs in Canada, 2012. Healthc Q. 2015;18(1):11\u20133.","journal-title":"Healthc Q"},{"issue":"5","key":"5027_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.12788\/jhm.2739","volume":"12","author":"EA Pek","year":"2017","unstructured":"Pek EA, Remfry A, Pendrith C, Fan-Lun C, Bhatia RS, Soong C. High Prevalence of Inappropriate Benzodiazepine and Sedative Hypnotic Prescriptions among Hospitalized Older Adults. J Hosp Med. 2017;12(5):310\u20136.","journal-title":"J Hosp Med"},{"issue":"2","key":"5027_CR6","first-page":"225","volume":"162","author":"AM Holbrook","year":"2000","unstructured":"Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162(2):225\u201333.","journal-title":"CMAJ"},{"key":"5027_CR7","first-page":"416864","volume":"2012","author":"CH Vinkers","year":"2012","unstructured":"Vinkers CH, Olivier B. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators? Adv Pharmacol Sci. 2012;2012:416864.","journal-title":"Adv Pharmacol Sci"},{"issue":"4","key":"5027_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","volume":"17","author":"J Brandt","year":"2017","unstructured":"Brandt J, Leong C. Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research. Drugs R D. 2017;17(4):493\u2013507.","journal-title":"Drugs R D"},{"issue":"11","key":"5027_CR9","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.clinthera.2016.09.010","volume":"38","author":"JL Schroeck","year":"2016","unstructured":"Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, et al. Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther. 2016;38(11):2340\u201372.","journal-title":"Clin Ther"},{"issue":"4","key":"5027_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40266-015-0251-3","volume":"32","author":"C Tannenbaum","year":"2015","unstructured":"Tannenbaum C, Diaby V, Singh D, Perreault S, Luc M, Vasiliadis HM. Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective. Drugs Aging. 2015;32(4):305\u201314.","journal-title":"Drugs Aging"},{"issue":"6","key":"5027_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging de fi nition of \u201cdeprescribing\u201d with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"5027_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/metabo11040254","volume":"11","author":"AF Rasmussen","year":"2021","unstructured":"Rasmussen AF, Poulsen SS, Oldenburg LIK, Vermehren C. The barriers and facilitators of different stakeholders when Deprescribing Benzodiazepine receptor agonists in older patients-a systematic review. Metabolites. 2021;11(4):254.","journal-title":"Metabolites"},{"issue":"1","key":"5027_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","volume":"17","author":"P Evrard","year":"2022","unstructured":"Evrard P, Petein C, Beuscart JB, Spinewine A. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement Sci. 2022;17(1):41.","journal-title":"Implement Sci"},{"issue":"1","key":"5027_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13012-017-0605-9","volume":"12","author":"L Atkins","year":"2017","unstructured":"Atkins L, Francis J, Islam R, O\u2019Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77.","journal-title":"Implement Sci"},{"issue":"8","key":"5027_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00228-017-2257-8","volume":"73","author":"E Reeve","year":"2017","unstructured":"Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73(8):927\u201335.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9596","key":"5027_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"key":"5027_CR17","doi-asserted-by":"publisher","first-page":"239920262092250","DOI":"10.1177\/2399202620922507","volume":"4","author":"N Kennie-Kaulbach","year":"2020","unstructured":"Kennie-Kaulbach N, Cormier R, Kits O, Reeve E, Whelan AM, Martin-Misener R, et al. Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks. Med Access Point Care. 2020;4:2399202620922507.","journal-title":"Med Access Point Care"},{"issue":"2","key":"5027_CR18","doi-asserted-by":"publisher","first-page":"e066234","DOI":"10.1136\/bmjopen-2022-066234","volume":"13","author":"MS Keller","year":"2023","unstructured":"Keller MS, Carrascoza-Bolanos J, Breda K, Kim LY, Kennelty KA, Leang DW, et al. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study. BMJ Open. 2023;13(2):e066234.","journal-title":"BMJ Open"},{"issue":"12","key":"5027_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40266-022-00985-4","volume":"39","author":"RA Kalim","year":"2022","unstructured":"Kalim RA, Cunningham CJ, Ryder SA, McMahon NM. Deprescribing Medications that Increase the Risk of Falls in Older People: Exploring Doctors\u2019 Perspectives Using the Theoretical Domains Framework (TDF). Drugs Aging. 2022;39(12):935\u201347.","journal-title":"Drugs Aging"},{"issue":"1","key":"5027_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12913-020-05744-y","volume":"20","author":"B Walraven","year":"2020","unstructured":"Walraven B, Ponjee G, Heideman W, Carkit FK. Medication reviews in hospitalized patients: a qualitative study on perceptions of primary and secondary care providers on interprofessional collaboration. BMC Health Serv Res. 2020;20(1):902.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"5027_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamainternmed.2022.6545","volume":"183","author":"EE Vasilevskis","year":"2023","unstructured":"Vasilevskis EE, Shah AS, Hollingsworth EK, Shotwell MS, Kripalani S, Mixon AS, et al. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial. JAMA Intern Med. 2023;183(3):223\u201331.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"5027_CR22","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.sapharm.2021.06.025","volume":"18","author":"M McCarthy","year":"2022","unstructured":"McCarthy M, Mak S, Kaufmann CN, Lum HD, Fung CH. Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists. Res Social Adm Pharm. 2022;18(4):2691\u20134.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"5027_CR23","first-page":"39","volume":"14","author":"J Shaw","year":"2019","unstructured":"Shaw J, Murphy AL, Turner JP, Gardner DM, Silvius JL, Bouck Z, et al. Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults. Healthc Policy. 2019;14(4):39\u201351.","journal-title":"Healthc Policy"},{"key":"5027_CR24","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796023000057","volume":"32","author":"L Garattini","year":"2023","unstructured":"Garattini L, Barbato A, D\u2019Avanzo B, Nobili A. Including mental health care in a model of European health system. Epidemiol Psychiatr Sci. 2023;32: e12.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"4","key":"5027_CR25","first-page":"1","volume":"22","author":"T Rice","year":"2020","unstructured":"Rice T, Rosenau P, Unruh LY, Barnes AJ. United States: Health System Review. Health Syst Transit. 2020;22(4):1\u2013441.","journal-title":"Health Syst Transit"},{"issue":"573","key":"5027_CR26","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.3399\/bjgp10X483922","volume":"60","author":"A Lasserre","year":"2010","unstructured":"Lasserre A, Younes N, Blanchon T, Cantegreil-Kallen I, Passerieux C, Thomas G, et al. Psychotropic drug use among older people in general practice: discrepancies between opinion and practice. Br J Gen Pract. 2010;60(573):e156\u201362.","journal-title":"Br J Gen Pract"},{"key":"5027_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.smrv.2014.06.010","volume":"19","author":"FY Ho","year":"2015","unstructured":"Ho FY, Chung KF, Yeung WF, Ng TH, Kwan KS, Yung KP, et al. Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev. 2015;19:17\u201328.","journal-title":"Sleep Med Rev"},{"issue":"2","key":"5027_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s40675-017-0065-4","volume":"3","author":"AI Luik","year":"2017","unstructured":"Luik AI, Kyle SD, Espie CA. Digital Cognitive Behavioral Therapy (dCBT) for Insomnia: a State-of-the-Science Review. Curr Sleep Med Rep. 2017;3(2):48\u201356.","journal-title":"Curr Sleep Med Rep"},{"issue":"4","key":"5027_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/hex.12487","volume":"20","author":"M Sustersic","year":"2017","unstructured":"Sustersic M, Gauchet A, Foote A, Bosson JL. How best to use and evaluate Patient Information Leaflets given during a consultation: a systematic review of literature reviews. Health Expect. 2017;20(4):531\u201342.","journal-title":"Health Expect"},{"issue":"12","key":"5027_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/2042098618804490","volume":"9","author":"JP Turner","year":"2018","unstructured":"Turner JP, Richard C, Lussier MT, Lavoie ME, Farrell B, Roberge D, et al. Deprescribing conversations: a closer look at prescriber-patient communication. Ther Adv Drug Saf. 2018;9(12):687\u201398.","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"5027_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890\u20138.","journal-title":"JAMA Intern Med"},{"key":"5027_CR32","doi-asserted-by":"publisher","first-page":"204209862090961","DOI":"10.1177\/2042098620909610","volume":"11","author":"AJ Poots","year":"2020","unstructured":"Poots AJ, Jubraj B, Ward E, Wycoco A, Barnett N. Education around medication review and deprescribing: a survey of medical and pharmacy students\u2019 perspectives. Ther Adv Drug Saf. 2020;11:2042098620909610.","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"5027_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s43058-020-00096-4","volume":"1","author":"E Koffel","year":"2020","unstructured":"Koffel E, Hagedorn H. Provider perspectives of implementation of an evidence-based insomnia treatment in Veterans Affairs (VA) primary care: barriers, existing strategies, and future directions. Implement Sci Commun. 2020;1(1):107.","journal-title":"Implement Sci Commun"},{"issue":"3","key":"5027_CR34","first-page":"41","volume":"14","author":"C Cheng","year":"2023","unstructured":"Cheng C, Papadakos J, Umakanthan B, Fazelzad R, Martimianakis MAT, Ugas M, et al. On the advantages and disadvantages of virtual continuing medical education: a scoping review. Can Med Educ J. 2023;14(3):41\u201374.","journal-title":"Can Med Educ J"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-05027-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-05027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T04:02:34Z","timestamp":1714795354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-05027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5027"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-05027-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,4]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was waived from approval by the local ethical committee (\u201cKantonale Ethikkommission Bern\u201d), because it did not fall under the Swiss Human Research Law (request number 2022\u201301423). Participation was voluntary, and participants provided consent for interview\/FG recording. They were informed that their name would appear nowhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}